Status:
RECRUITING
Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study
Lead Sponsor:
Istituto Auxologico Italiano
Collaborating Sponsors:
Politecnico di Milano
Conditions:
Acromegaly
Eligibility:
All Genders
18-90 years
Brief Summary
Acromegaly is a rare chronic disease due to excessive secretion of growth hormone (GH) and insulin-like growth factor-I (IGF-I), caused in over 98% of cases by GH-secreting pituitary adenoma. Prolonge...
Detailed Description
This is an observational, prospective study that aims to evaluate the effect of acromegalic disease and medical/surgical therapy on acral morpho-functional alterations. To outline the morphological c...
Eligibility Criteria
Inclusion
- De novo patients with acromegaly (group # 1), diagnosed according to Endocrine Society guidelines,
- Age equal to18 years or older
- Acromegalic patients with different disease status (group #2)
- Age equal to18 years or older
Exclusion
- Cardiorespiratory, neurological or musculoskeletal disorder
- Previous orthopaedic surgery
- Previous lower limbs traumatic injuries
Key Trial Info
Start Date :
June 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05964712
Start Date
June 18 2019
End Date
December 31 2025
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Auxologico Italiano IRCCS San Luca
Milan, Italy, 20149